Subscribe To Our Newsletter
Stay up-to-date on the latest breaking news involving data breaches, class actions, and mass arbitrations.
If you’ve ever paid a premium for high-quality matcha to enjoy a smooth, vibrant tea at home, you may have been misled. A new class action lawsuit alleges that MatchaBar,
A long-awaited resolution is on the horizon for millions of Honda and Acura drivers. Honda has reached a proposed class action settlement to resolve allegations that it sold vehicles equipped
A federal judge has granted preliminary approval to a $7.85 million settlement with Sony Interactive Entertainment, resolving claims that the company maintained an illegal monopoly over digital PlayStation games. The
MUBI, the global film streaming service and distributor, has agreed to a $1.6 million settlement to resolve a class action lawsuit alleging the company failed to follow California’s strict laws
Investors who lost funds in the massive Drift Protocol exploit are taking a stand against Circle Internet Financial. A new class action lawsuit alleges that the stablecoin giant stood by
A recent class action lawsuit alleges that Wagner Spray Tech’s recall of over 700,000 power steamers is fundamentally flawed, leaving everyday people at risk of serious burn injuries. While the
If you have ever reached for a bottle of OLLY Metabolism Gummy Rings hoping for a natural boost to your weight loss journey, you might want to take a closer
A new class action lawsuit alleges that AARP and UnitedHealthcare Insurance Company have systematically defrauded senior citizens by denying Medigap claims based on hidden requirements. The lawsuit claims the companies
Investors who suffered significant financial losses with Alight, Inc. (NYSE: ALIT) are being urged to take action following the filing of a federal securities class action lawsuit. The case
KIND Healthy Grains Dark Chocolate Clusters are at the center of a new class action lawsuit alleging the product contains more than four times the allowable daily limit of lead
A class action lawsuit currently pending in the District of Massachusetts alleges that Takeda Pharmaceutical Company engaged in a “pay-for-delay” scheme to keep cheaper generic versions of the constipation drug
If you invested in Nektar Therapeutics (NASDAQ: NKTR) and saw the value of your savings plummet, you are not alone. A federal class action lawsuit has been filed against the
